Hillcrest Hospital South Receives ACC Chest Pain Center with Primary PCI Accreditation
The American College of Cardiology (ACC) has recognized Hillcrest Hospital South for its demonstrated expertise and commitment in treating patients with chest pain. Hillcrest Hospital South was awarded Chest Pain Center Accreditation with Primary PCI in April based on rigorous onsite evaluation of the staff’s ability to evaluate, diagnose and treat patients who may be experiencing a heart attack.
Is flu season over? Not yet, according to local doctors.
TULSA, Okla. (April 4, 2018) – Is the flu season over? Not quite, according to doctors.
This flu season has been especially brutal, resulting in more than 4,500 hospitalizations and, tragically, 253 deaths from Sept. 1, 2017 – March 20, 2018 according to the Oklahoma State Department of Health (OSDH). OSDH reported no new deaths resulting from influenza from March 21 – March 27, 2018, though during the same time period 27 Oklahomans were hospitalized due to flu complications.
Hillcrest Medical Center Receives Excellence Through Insight Award from National Health Care Organization
Hillcrest Medical Center (HMC) was recently recognized with an Excellence Through Insight award from HealthStream, Inc, a national health care organization focused on improving patient outcomes through the development of the health care workforce.
The awards are given annually to HealthStream clients who perform above industry and peer benchmark levels in a variety of categories. HMC was recognized for Most Improved Outpatient Satisfaction in the large hospital category (250+ beds) based on 2015 HealthStream data primarily collected from patient telephone surveys.
Oklahoma Heart Institute implants first-of-its-kind naturally dissolving heart stent in patient with coronary artery disease
Tulsa, OK (August 23, 2016) Oklahoma Heart Institute (OHI) recently became one of the first hospitals in Oklahoma to offer patients with coronary artery disease a new treatment option that literally disappears over time.
Mary Seago of Liberty Mounds, OK, was the first OHI patient to be implanted with the world's first FDA-approved dissolving heart stent. The Absorb bioresorbable vascular scaffold is a major advancement in the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide.
Contact Your Legislators
To begin, please provide the following information.